Ciprofloxacin vs Durvalumab

## Ciprofloxacin vs Durvalumab: Overview

This comparison examines the pharmacological differences between **Ciprofloxacin** and **Durvalumab**.

## Mechanism of Action

**Ciprofloxacin**: Inhibits bacterial DNA gyrase and topoisomerase IV.

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

## Pharmacokinetics

**Half-life**: Ciprofloxacin — 4 hours; Durvalumab — 17 days.

## Chemical Properties

**Molecular Formula**: Ciprofloxacin — C17H18FN3O3; Durvalumab — N/A.

**Molecular Weight**: Ciprofloxacin — 331.3460 g/mol; Durvalumab — N/A.

**Type**: Ciprofloxacin — Small molecule; Durvalumab — Antibody.